Publications

Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypes.

Authors: RS Adam, D Poel, L Ferreira Moreno, JMA Spronck, TR de Back, A Torang, PM G...

E-pub date: 1 Jul 2022

Journal name: Mol Oncol

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial.

Authors: AR Clamp, EC James, IA McNeish, A Dean, J-W Kim, DM O'Donnell, D Gallardo-R...

E-pub date: 1 Jul 2022

Journal name: Lancet Oncol

Imaging Glioblastoma Metabolism by Using Hyperpolarized [1-13C]Pyruvate Demonstrates Heterogeneity in Lactate Labeling: A Proof of Principle Study.

Authors: F Zaccagna, MA McLean, JT Grist, J Kaggie, R Mair, F Riemer, R Woitek, AB G...

E-pub date: 1 Jul 2022

Journal name: Radiol Imaging Cancer

The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma.

Authors: Z Cheng, H Mirza, DP Ennis, P Smith, L Morrill Gavarró, C Sokota, G Gianno...

E-pub date: 1 Jul 2022

Journal name: Clin Cancer Res

SHLD1 is dispensable for 53BP1-dependent V(D)J recombination but critical for productive class switch recombination.

Authors: E Vincendeau, W Wei, X Zhang, C Planchais, W Yu, H Lenden-Hasse, T Cokelaer...

E-pub date: 28 Jun 2022

Journal name: Nat Commun

Abstract 53: The copy number landscape of early stage ovarian high grade serous carcinoma

Authors: Z Cheng, HB Mirza, DP Ennis, P Smith, LM Gavarró, C Sokota, G Giannone, T ...

E-pub date: 15 Jun 2022

Journal name: Cancer Research

Abstract 476: Predicting response to treatment in early breast cancer using dynamic integrative multi-omic profiling

Authors: S-J Sammut, M Crispin-Ortuzar, S-F Chin, E Provenzano, W Cope, A Dariush, S...

E-pub date: 15 Jun 2022

Journal name: Cancer Research

Tracing back to one of the origins of immune evasion in pancreatic cancer.

Authors: J Araos Henríquez, G Biffi

E-pub date: 13 Jun 2022

Journal name: Cancer Cell

Filters

Research Groups

Core Facilities

Start date

End date

Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypes.

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial.

Imaging Glioblastoma Metabolism by Using Hyperpolarized [1-13C]Pyruvate Demonstrates Heterogeneity in Lactate Labeling: A Proof of Principle Study.

The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma.

SHLD1 is dispensable for 53BP1-dependent V(D)J recombination but critical for productive class switch recombination.

Abstract 53: The copy number landscape of early stage ovarian high grade serous carcinoma

Abstract 476: Predicting response to treatment in early breast cancer using dynamic integrative multi-omic profiling

Tracing back to one of the origins of immune evasion in pancreatic cancer.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypes.

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial.

Imaging Glioblastoma Metabolism by Using Hyperpolarized [1-13C]Pyruvate Demonstrates Heterogeneity in Lactate Labeling: A Proof of Principle Study.

The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma.

SHLD1 is dispensable for 53BP1-dependent V(D)J recombination but critical for productive class switch recombination.

Abstract 53: The copy number landscape of early stage ovarian high grade serous carcinoma

Abstract 476: Predicting response to treatment in early breast cancer using dynamic integrative multi-omic profiling

Tracing back to one of the origins of immune evasion in pancreatic cancer.